In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Perumal Samy, R ^a   Pachiappan, A ^a   Gopalakrishnakone, P ^a   Thwin, Maung M ^a   Hian, Yap E ^b   Chow, Vincent T K ^b   Bow, Ho ^b   Weng, Joseph T ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID OXIDASE; AMMODYTOXIN A; ANTIINFECTIVE AGENT; BEE VENOM; BETA BUNGAROTOXIN; CEFTAZIDIME; CHLORAMPHENICOL; CROTOXIN A; CROTOXIN B; DABOIATOXIN; MOJAVE TOXIN; MULGATOXIN; PHOSPHOLIPASE A2; SCORPION VENOM; SNAKE VENOM; STREPTOMYCIN; TAIPOXIN; TETRAZOLIUM; TOXIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BURKHOLDERIA PSEUDOMALLEI; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DIFFUSION; DILUTION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY;

ANIMALS; BURKHOLDERIA PSEUDOMALLEI; CROTOXIN; DRUG RESISTANCE, MICROBIAL; HUMANS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; PHOSPHOLIPASES A; PHOSPHOLIPASES A2; PROTEINS; SEPSIS; SNAKE VENOMS;

EID: 33748889901     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-100     Document Type: Article

References (44)

1. Chaowagul W, White NJ, Dance DAB, Wattanagoon Y, Naigowit P, Davis TME, Looareesuwan S, Pitakwatchara N: Melioidosis: a major cause of community acquired septicemia in northeastern Thailand. J Infect Dis 1989, 159:890-899.
2. Yabuuchi E, Arakawa M: Burkholderia pseudomallei and melioidosis: be aware in temperate area. Microbiol Immunol 1993, 37:823-836.
3. Puthucheary SD, Parasakthi N, Lee MK: Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans Roy Soc Trop Med Hyg 1992, 86:683-685.
4. White NJ: Melioidosis. Lancet 2003, 361:1715-1722.
5. Currie BJ, Fisher DA, Howard DM: Endemic melioidosis in tropical northern Australia a 10 year perspective study and review of the literature. Clin Infect Dis 2000, 31:981-986.
6. Hsuch PR, Teng LJ, Lee LN: Melioidosis: an emerging infection in Taiwan? Emerging Infect Dis 2001, 7:428-433.
7. Yang S: Melioidosis research in China. Acta Tropica 2000, 77:157-165.
8. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattara-arechai J, White NJ: Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993, 168:1181-1185.
9. Simpson AJH, Smith MD, Weverling GJ: Prognostic value of cytokine concentratons (tumor necrosis factor, interleukin 6 and interleukin 10) and clinical parameter in severe melioidosis. J Infect Dis 2000, 181:621-625.
10. Nuntayanuwat S, Dharakul T, Chaowagal W, Songsivilai S: Polymorphism in the promtor region of tumor necrosis factor-alpha gene is associated with severe melioidosis. Human Immunol 1999, 60:979-983.
11. Bonomo RA: Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis 2000, 31:1414-1422.
12. Dance DAB: Melioidosis. In Manson's tropical diseases 20th edition. Edited by: Cook GC. London, England: W B. Saunders Co. Ltd; 1996:925-930.
13. Leelarasamee A: Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J Trop Med Public Health 1998, 29:410-415.
14. Eickhoff TC, Bennett JV, Hayes PS, Feeley J: Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents. J Infect Dis 1970, 121:95-102.
15. Jones AL, Beveridge TJ, Woods DE: Intracellular survival of Burkholderia pseudomallei. Infect Immu 1996, 64:782-790.
16. Ganz T, Lehrer RI: Antimicrobial peptides of leukocytes. Current Opinion in Haematology 1997, 4:53-58.
17. 2 from Bothrops asper snake venoms-sythectic Lys49 myotoxin II- (115-129)-peptide identifies its bactericidal region. Europ J Biochem 1998, 253:452-461.
18. 2 from Bothrops neuwiedi pauloensis snake venom. Toxicon 2004, 44:305-314.
19. Stiles BG, Sexton FW, Weinstein SA: Antibacterial effects of different snake venoms: purification and characterisation of antibacterial proteins from Pseudechis australis (Australian king brown or Mulga snake) venom. Toxicon 1991, 29:1129-1141.
20. Corzo G, Escoubas P, Villegas E, Barnham KJ, Weilan HE, Norton RS, Nakajima T: Characterization of unique amphipathic antibacterial peptides from venom of the scorpion Pandinus imperator. J Biochem 2001, 359:35-45.
21. Possani LD, Zurita M, Delepierre M, Hernandez FH, Rodriguez MH: From noxiustoxin to Shiva-3, a peptide toxic to the sporogonic development of Plasmodium berghei. Toxicon 1998, 36:1683-1692.
22. Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA: De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolfspider Lycosa Singoriensis. J Mass Spectrometry 2004, 39:193-201.
23. Haeberli S, Kuhn-Nentwig L, Schaller J, Nentwig W: Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae). Toxicon 2000, 38:373-380.
24. Fennel JE, Shipman WH, Cole LJ: Antibacterial action of melittin, a polypeptide from the venom. Proc Soc Exp Biol Med 1968, 127:707-710.
25. Stocker JF, Traynor JR: The action of various venoms on Escherichia coli. J Applied Bacteriol 1986, 61:383-88.
26. Hancock REW: Peptide antibiotics. Lancet 1997, 349:418-422.
27. Hancock RE, Scott MG: The role of antimicrobial peptides in animal defenses. Proc Natl Acade Sci USA 2000, 97:8856-8861.
28. Silphaduang U, Noga EJ: Antimicrobials-peptide antibiotics in mast cells of fish. Nature 2001, 414:268-269.
29. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard. M2-A6. National Committee for Clinical Standards, Wayne Pennsyvania. 1997.
30. Thwin MM, Gopalakrishnakone P, Yuen R, Tan CH: A major lethal factor of the venom of Burmese Reussell's viper (Daboia russelli siamensis): Isolation, N-terminal sequencing and biological activities of daboiatoxin. Toxicon 1995, 33:63-76.
31. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A4. National Committee for Clinical Standards, Wayne Pennsyvania. 1997.
32. Amsterdam D: Susceptibility testing of antimicrobials in liquid media. In Antibiotics in laboratory medicine 4th edition. Edited by: Lorian V. Baltimore, MD: Williams and Wilkins; 1996:52-111.
33. 2 on short chain phosphatidycholine-mixed micelles: Development of a spectrophotometric assay suitable for a microtiterplate reader. Ann Biochem 1992, 204:190-197.
34. Bradford MM: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 1976, 72:248-254.
35. Pachiappan A, Thwin MM, Manikandan J, Gopalakrishnakone P: Glial inflammation and neurodegeneration induced by candoxin, a novel neurotoxin from Bungarus candidus venom: global gene expression analysis using microarray. Toxicon 2005, 46:883-899.
36. Talan DA, Citron DM, Overturf GD, Singer B, Froman P, Goldstein EJ: Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. J Infect Dis 1991, 164:195-198.
37. Blaylock RSM: Antibacterial properties of KwaZulu Natal snake venoms. Toxicon 2000, 38:1529-1534.
38. 2 isolated from Crotalus durissus terrificus venom. J Protein Chem 2002, 21:161-168.
39. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ: A perspective comparision of co-amoxiclav and the combination of chloramphenicol, doxycycline and co-trimoxazole for the oral maintenance treatment of melioidosis. Br J Clin Pharmacology 2000, 49:184-191.
40. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N: Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989, 2:697-701.
41. 2-like precursor. Biochem Biophys Acta 1991, 1088:401-408.
42. Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF: Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother 2001, 45:2838-2844.
43. Sahly H, Schubert S, Harder J, Rautenberg P, Ullmann U, Schröder J, Podschun R: Burkholderia is highly resistant to human Betadefensin 3. Antimicrob Agents Chemother 2003, 47:1739-1741.
44. Loutet SA, Flannagan RS, Kooi C, Sokol PA, Valvanol MA: A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 2006, 18:2073-2080.